Intelica CRETM transcended its traditional broker role to create growth for a St. Louis legacy. In 2015, Intelica partnered with Lee Biosolutions to identify, acquire, build-out and re-capitalize a state-of-the-art laboratory facility in Maryland Heights. Lee Biosolutions, a multi-generational St. Louis company, synthesizes animal proteins for the medical diagnostic industry worldwide and projects $11 million in revenue for 2017, up from over $9 million in 2016.
\"Intelica helped me create equity to off-set that cost and utilize it for growth. Everyday I’m blessed when I walk into this building Burton Lee\", CEO, Lee Biosolutions
Owner/CEO Burton Lee first engaged Intelica CRE in 2008 after a flood clarified his company’s need for a larger lab facility. In 2015, Dokovic helped Lee secure an off-market deal for a building formerly owned by now-defunct KV Pharmaceuticals.
Intelica emphasizes growth potential and capitalization. Lee purchased the building for under $1 million, at 16.79% of the previous loan balance and 6.9% of its replacement value. The 41,000 square feet facility combines unique design features with existing lab space that vastly expanded Lee Biosolutions’ ability to reach customers in the global market